Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B.read more
Alexander Kuta ā Senior Vice President Regulatory Affairs at uniQure
Executive Bio
Alexander Kuta serves as the Senior Vice President Regulatory Affairs of uniQure. Alexander started at uniQure in January of 2017. Alexander currently resides in the Greater Boston Area.
Executive Team Culture Ratings from uniQure Employees
TOP
10%
uniQure's Executive Team scores in the Top 10% of similar sized companies on Comparably